SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K/A - Current report: [Amend]
SEC Accession No. 0001607062-19-000113
Filing Date
2019-03-22
Accepted
2019-03-22 16:40:22
Documents
5
Period of Report
2019-01-07
Items
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K/A gnbt031219form8ka.htm 8-K/A 28802
2 EXHIBIT 23.1 ex23_1.htm EX-23.1 2824
3 EXHIBIT 99.1 ex99_1.htm EX-99.1 110081
4 EXHIBIT 99.2 ex99_2.htm EX-99.2 185369
5 EXHIBIT 99.3 ex99_3.htm EX-99.3 286548
  Complete submission text file 0001607062-19-000113.txt   614652
Mailing Address 10102 USA TODAY WAY MIRAMAR FL 33025
Business Address 10102 USA TODAY WAY MIRAMAR FL 33025 416-364-2551
GENEREX BIOTECHNOLOGY CORP (Filer) CIK: 0001059784 (see all company filings)

IRS No.: 820490211 | State of Incorp.: DE | Fiscal Year End: 0731
Type: 8-K/A | Act: 34 | File No.: 000-25169 | Film No.: 19700365
SIC: 2834 Pharmaceutical Preparations